Emiliano Fabiani

15PUBLICATIONS
62CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursGene and molecular therapyReproductive medicine not elsewhere classifiedGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 01, 2026
Prognostic Impact of FLT3-ITD Microclones in AML: An EHA AML-Specialized Working Group Study.

|Apr 09, 2026
A case of T-prolymphocytic leukemia harboring RAS mutation.

Salvatore Perrone, Giada Pacitto, Alessia Tirnetta

|Jun 16, 2023
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting.

Enrico Attardi, Arianna Savi, Beatrice Borsellino

|Mar 12, 2022
Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy.

Maria-Teresa Voso, Tatjana Pandzic, Giulia Falconi

|May 27, 2021
Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia.

Emiliano Fabiani, Laura Cicconi, Anna Maria Nardozza

|May 10, 2021
Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML.

Bon Q Trinh, Simone Ummarino, Yanzhou Zhang

Pageof 3

Frequent Collaborators

13 joint publications

Maria-Teresa Voso

6 joint publications

Giulia Falconi

5 joint publications

Carmelo Gurnari

2 joint publications

Jaroslaw P Maciejewski